Skip Navigation

An Open-Label, Multicenter Phase 1/2 Study to Evaluate the Safety and Efficacy of AB-3028 in Patients with Castration Resistant Prostate Cancer CRPC

Brief Summary

Type:
Prostate

Study Type:
Treatment

Phase:
I/II

ClinicalTrials.gov Identifier:
NCT07285694

Study #:
STUDY00162311

Start Date:
May 28, 2026

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT07285694

View Complete Trial Details & Eligibility at ClinicalTrials.gov